Natalucci G, Latal B, Koller B, Ruegger C, et al. Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants. JAMA 2020;324:2324-2327.
PMID: 33289818